Equalan Pharma Europesp. z o.o.

Manufacture of perfumes and toilet preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2009-09-01
Share capital
400 000,00 PLN
Activity description

Equalan Pharma Europe is a Polish manufacturer of face, body and hair care cosmetics as well as dietary supplements, combining cosmetology, pharmacy and food technology. The company provides contract manufacturing and private-label services, operates its own research and development department, and produces goods in line with PN-EN ISO 22716:2009 (GMP), from formulation development through production.

Registered address
ul. Gen. Władysława Andersa 38A, 15-113 Białystok, Poland
Website
equalanpharma.euWebsite active
Email
Email address current
Phone
Social media
Electronic delivery address
AE:PL-14649-61111-IDWGR-31

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 6.27mMedianUSD 179.69kAverageUSD 6.37m
Net profit
This companyUSD 149.80kMedianUSD 2.07kAverageUSD 457.84k
Operating costs
This companyUSD 5.92mMedianUSD 174.20kAverageUSD 5.66m
Assets
This companyUSD 4.78mMedianUSD 163.79kAverageUSD 5.21m

Bank accounts

Registered as a VAT taxpayer on 2009-07-24. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

20 public aid cases recorded, with a total value of $646,562.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–

European Funds

ProjectEU co-financing
Promocja innowacyjnych produktów oferowanych przez EQUALAN na rynkach zagranicznych.
$12,026
Dotacja na kapitał obrotowy dla EQUALAN PHARMA EUROPE sp. z o.o.
$55,840

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Adam Mocarski – President of the Management Board
Justyna Kinga Mocarska – Management Board Member

Manner of representation

Each member of the management board independently.

Ownership

OwnerSharesShare valueStake
760$102,647.2250%
Mf Invest Sp. z o.o.
760$102,647.2250%

Beneficial owners

Person

Competitors

Name
Yopesp. z o.o.
Forte Swedensp. z o.o.
Popławska Groupsp. j.
Flosleksp. z o.o.
Scandia CosmeticsS.A.
Revers Cosmeticssp. z o.o.
City Cosmeticssp. z o.o.
Latechsp. z o.o.
Procosmetica sp. z o.o.sp. k.
Lefroschsp. z o.o.

Change history

DateEvent
2015-10-19Address change
2015-10-19PKD change
2011-07-21Address change
2011-07-21Share capital change
2010-05-14Share capital change

FAQ

Last updated: 2026-10-13